{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:04:09Z","timestamp":1768345449740,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.7759\/cureus.92009","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:33:37Z","timestamp":1757554417000},"source":"Crossref","is-referenced-by-count":1,"title":["Genotype Meets Phenotype: Unraveling Gaucher\u2019s Genetic Landscape in the Indian Population"],"prefix":"10.7759","author":[{"given":"Diana G","family":"Powline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnanapraba","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchanda","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam M","family":"Joel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praisy","family":"Joy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann J","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, et al.. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017, 18:441. 10.3390\/ijms18020441","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro AM","year":"2010","unstructured":"Vaccaro AM, Motta M, Tatti M, et al.. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting. Hum Mol Genet. 2010, 19:2987-97. 10.1093\/hmg\/ddq204","journal-title":"Hum Mol Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk L","year":"2017","unstructured":"Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017, 22:65-73. 10.1080\/10245332.2016.1240391","journal-title":"Hematology"},{"key":"ref4","article-title":"De L\u2019epithelioma Primitive de Las Rate, Hypertrophie Idiopathique de la Rate Sans Leucemie","author":"Gaucher PCE","year":"1885","unstructured":"Gaucher PCE. De L\u2019epithelioma Primitive de Las Rate, Hypertrophie Idiopathique de la Rate Sans Leucemie. Academic Thesis, Paris, Paris; 1885."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(65)90743-6","article-title":"Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady RO","year":"1965","unstructured":"Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease. Biochem Biophys Res Commun. 1965, 18:221-5. 10.1016\/0006-291x(65)90743-6","journal-title":"Biochem Biophys Res Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski GA","year":"2008","unstructured":"Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher's disease. Lancet. 2008, 372:1263-71. 10.1016\/S0140-6736(08)61522-6","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann J","year":"2012","unstructured":"Stirnemann J, Vigan M, Hamroun D, et al.. The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients. Orphanet J Rare Dis. 2012, 7:77. 10.1186\/1750-1172-7-77","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002506","article-title":"Global epidemiology of Gaucher disease: an updated systematic review and meta-analysis","volume":"45","author":"Wang M","year":"2023","unstructured":"Wang M, Li F, Zhang J, Lu C, Kong W. Global epidemiology of Gaucher disease: an updated systematic review and meta-analysis. J Pediatr Hematol Oncol. 2023, 45:181-8. 10.1097\/MPH.0000000000002506","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.61.2.484","article-title":"The fine structure of the cerebroside occurring in Gaucher's disease","volume":"61","author":"Lee RE","year":"1968","unstructured":"Lee RE. The fine structure of the cerebroside occurring in Gaucher's disease. Proc Natl Acad Sci U S A. 1968, 61:484-9. 10.1073\/pnas.61.2.484","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","unstructured":"Ask Hematologist. Gaucher\u2019s disease. (2016). Accessed. August 16, 2025: https:\/\/askhematologist.com\/gauchers-disease\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1309\/BG5V-A8JR-DQH1-M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven LA","year":"2004","unstructured":"Boven LA, van Meurs M, Boot RG, Mehta A, Boon L, Aerts JM, Laman JD. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol. 2004, 122:359-69. 10.1309\/BG5V-A8JR-DQH1-M7HN","journal-title":"Am J Clin Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen MJ","year":"1997","unstructured":"Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. QJM. 1997, 90:19-25. 10.1093\/qjmed\/90.1.19","journal-title":"QJM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen MJ","year":"2007","unstructured":"van Breemen MJ, de Fost M, Voerman JS, et al.. Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease. Biochim Biophys Acta. 2007, 1772:788-96. 10.1016\/j.bbadis.2007.04.002","journal-title":"Biochim Biophys Acta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-010-0841-y","article-title":"An overview on bone manifestations in Gaucher disease","volume":"160","author":"Mikosch P","year":"2010","unstructured":"Mikosch P, Hughes D. An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr. 2010, 160:609-24. 10.1007\/s10354-010-0841-y","journal-title":"Wien Med Wochenschr"},{"key":"ref15","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"14","author":"Sidransky E","year":"2012","unstructured":"Sidransky E. Gaucher disease: insights from a rare Mendelian disorder. Discov Med. 2012, 14:273-81.","journal-title":"Discov Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann RH","year":"2000","unstructured":"Lachmann RH, Wight DG, Lomas DJ, Fisher NC, Schofield JP, Elias E, Cox TM. Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features. QJM. 2000, 93:237-44. 10.1093\/qjmed\/93.4.237","journal-title":"QJM"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow J","year":"2000","unstructured":"Charrow J, Andersson HC, Kaplan P, et al.. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000, 160:2835-43. 10.1001\/archinte.160.18.2835","journal-title":"Arch Intern Med"},{"key":"ref18","article-title":"Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy","volume":"2","author":"Kauli R","year":"2000","unstructured":"Kauli R, Zaizov R, Lazar L, et al.. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy. Isr Med Assoc J. 2000, 2:158-63.","journal-title":"Isr Med Assoc J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.10.1353","article-title":"The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations","volume":"65","author":"Goker-Alpan O","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol. 2008, 65:1353-7. 10.1001\/archneur.65.10.1353","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann RH","year":"2004","unstructured":"Lachmann RH, Grant IR, Halsall D, Cox TM. Twin pairs showing discordance of phenotype in adult Gaucher's disease. QJM. 2004, 97:199-204. 10.1093\/qjmed\/hch036","journal-title":"QJM"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2014.5","article-title":"Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease","volume":"59","author":"Ankleshwaria C","year":"2014","unstructured":"Ankleshwaria C, Mistri M, Bavdekar A, et al.. Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease. J Hum Genet. 2014, 59:223-8. 10.1038\/jhg.2014.5","journal-title":"J Hum Genet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref23","article-title":"Critical Appraisal Checklist for Prevalence Studies","author":"Martin J","year":"2017","unstructured":"Martin J. Critical Appraisal Checklist for Prevalence Studies. Joanna Briggs Institute, Adelaide, Australia; 2017."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03300-z","article-title":"Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre","volume":"19","author":"Sheth J","year":"2024","unstructured":"Sheth J, Nair A, Sheth F, et al.. Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre. Orphanet J Rare Dis. 2024, 19:295. 10.1186\/s13023-024-03300-z","journal-title":"Orphanet J Rare Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000514507","article-title":"Clinicogenetic profile, treatment modalities, and mortality predictors of Gaucher disease: a 15-year retrospective study","volume":"24","author":"Barney AM","year":"2021","unstructured":"Barney AM, Danda S, Abraham A, et al.. Clinicogenetic profile, treatment modalities, and mortality predictors of Gaucher disease: a 15-year retrospective study. Public Health Genomics. 2021, 24:139-48. 10.1159\/000514507","journal-title":"Public Health Genomics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29868","article-title":"Targeted screening for Gaucher disease in high suspicion patients and clinical profile of screen positives in a large pediatric multispecialty hospital","volume":"14","author":"Magar S","year":"2022","unstructured":"Magar S, Engade M, Idhate T, Khambayate S, Nilofer S, Kalia A. Targeted screening for Gaucher disease in high suspicion patients and clinical profile of screen positives in a large pediatric multispecialty hospital. Cureus. 2022, 14:e29868. 10.7759\/cureus.29868","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_1009_20","article-title":"Lysosomal storage disorders: clinical, biochemical and molecular profile from rare disease centre, India","volume":"24","author":"Goyal M","year":"2021","unstructured":"Goyal M, Gupta A. Lysosomal storage disorders: clinical, biochemical and molecular profile from rare disease centre, India. Ann Indian Acad Neurol. 2021, 24:686-92. 10.4103\/aian.AIAN_1009_20","journal-title":"Ann Indian Acad Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-012-0192-4","article-title":"Spectrum of lysosomal storage disorders at a medical genetics center in northern India","volume":"49","author":"Verma PK","year":"2012","unstructured":"Verma PK, Ranganath P, Dalal AB, Phadke SR. Spectrum of lysosomal storage disorders at a medical genetics center in northern India. Indian Pediatr. 2012, 49:799-804. 10.1007\/s13312-012-0192-4","journal-title":"Indian Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-016-0910-4","article-title":"Outcome of Gaucher Disease in India: Lessons from Prevalent Diagnostic and Therapeutic Practices","volume":"53","author":"Muranjan M","year":"2016","unstructured":"Muranjan M, Patil S. Outcome of Gaucher Disease in India: Lessons from Prevalent Diagnostic and Therapeutic Practices. Indian Pediatr. 2016, 53:685-8. 10.1007\/s13312-016-0910-4","journal-title":"Indian Pediatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-018-0687-5","article-title":"Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India","volume":"19","author":"Sheth J","year":"2018","unstructured":"Sheth J, Pancholi D, Mistri M, et al.. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India. BMC Med Genet. 2018, 19:178. 10.1186\/s12881-018-0687-5","journal-title":"BMC Med Genet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0759-1","article-title":"Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation","volume":"20","author":"Sheth J","year":"2019","unstructured":"Sheth J, Bhavsar R, Mistri M, et al.. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet. 2019, 20:31. 10.1186\/s12881-019-0759-1","journal-title":"BMC Med Genet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak CE","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994, 93:1288-92. 10.1172\/JCI117084","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-014-9711-x","article-title":"Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy","volume":"37","author":"van Dussen L","year":"2014","unstructured":"van Dussen L, Hendriks EJ, Groener JE, Boot RG, Hollak CE, Aerts JM. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy. J Inherit Metab Dis. 2014, 37:991-1001. 10.1007\/s10545-014-9711-x","journal-title":"J Inherit Metab Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan V","year":"2016","unstructured":"Murugesan V, Chuang WL, Liu J, et al.. Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol. 2016, 91:1082-9. 10.1002\/ajh.24491","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405720-genotype-meets-phenotype-unraveling-gauchers-genetic-landscape-in-the-indian-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:33:39Z","timestamp":1757554419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405720-genotype-meets-phenotype-unraveling-gauchers-genetic-landscape-in-the-indian-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.92009","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}